The FDA has approved a novel diagnostic for prostate cancer that looks to improve upon the common screener for prostate-specific antigen, known as a PSA test. The IsoPSA blood test, developed by ...
Cleveland Diagnostics said Monday it received Food and Drug Administration approval for a test that analyzes the structure of protein biomarkers in the blood for prostate cancer signals, to aid in ...
Cofounding CEO Arnon Chait to remain with company as Chief Innovation Officer Cleveland Diagnostics, Inc., a pioneering, commercial-stage precision oncology company, has named Michael Iskra as its new ...
The tests have not been approved by federal regulators, but that hasn’t stopped patients from wanting them — and doctors from worrying. By Nina Agrawal In the spring of 2021, the cancer field was ...
Forbes contributors publish independent expert analyses and insights. Joshua Cohen is a Boston-based writer who covers health policy. This voice experience is generated by AI. Learn more. This voice ...
Multicancer early detection tests hold great promise for finding cancer early enough to save lives, but there are caveats ...
Secondary Cancers After NSCLC: What’s the Risk? Among survivors of non-small cell lung cancer, nearly 8% developed non-lung secondary cancers over about 6 years, and this risk may be driven by genetic ...
Add Yahoo as a preferred source to see more of our stories on Google. A young person is undergoing a diagnostic medical imaging procedure. “We believe in screening so deeply because psychologically, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results